| タイトル |
Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
|
| 著者 |
Inoue Daisuke
Muraoka Ryoichi
Okazaki Ryo
Nishizawa Yoshiki
|
| 収録物名 |
CALCIFIED TISSUE INTERNATIONAL
|
| 巻 | 98 |
| 号 | 2 |
| 開始ページ | 114 |
| 終了ページ | 122 |
| 収録物識別子 |
ISSN 0171-967X
EISSN 1432-0827
|
| 主題 |
Bisphosphonate; Risedronate; Metabolic syndrome; Life style-related disease; Bone mineral density; Bone turnover markers
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
SPRINGER
|
| 発行日 | 2016-02 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[PMID]
26466937
|
| 備考 | This study was supported by the Joint Development Program of Ajinomoto Pharmaceuticals Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by Ajinomoto Pharmaceuticals Co., Ltd. |
